Context Therapeutics Inc. (CNTX)

AI Score

Unlock

0.91

0.08 (9.11%)

At close: Apr 22, 2025, 3:59 PM

0.88

-3.99%

After-hours: Apr 22, 2025, 04:30 PM EDT

Context Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q1 2020
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Mar 31, 2020
Cash & Equivalents	94.43M	84.8M	101.54M	10.09M	14.45M	21.68M	25.14M	29.77M	35.5M	39.43M	42.92M	45.73M	49.64M	419.15K	1.28M	1.66M	341.04K	-226.6K
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	453.21K
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	50.39K	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	n/a	n/a	n/a	n/a	-1	n/a	24K	26.19K	32.75K	39.31K	67.75K	24K	n/a	1.82M	1.42M	580.72K	117.63K	-226.6K
Receivables	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	3.47M	1.27M	1.16M	949.49K	1.6M	1.29M	2.57M	2.12M	2.36M	2.51M	1.58M	1.13M	1.62M	18.38K	n/a	n/a	n/a	n/a
Total Current Assets	97.9M	86.07M	102.7M	11.04M	16.05M	22.97M	27.71M	31.89M	37.85M	41.94M	44.5M	46.86M	51.26M	437.53K	1.3M	1.67M	349.71K	226.6K
Property-Plant & Equipment	230.78K	259.03K	10.39K	12.96K	15.52K	18.09K	28.7K	54.27K	79.53K	104.51K	129.21K	151.47K	n/a	n/a	n/a	n/a	n/a	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	230.78K	259.03K	10.39K	12.96K	15.52K	18.09K	52.7K	80.45K	112.28K	143.83K	196.96K	175.47K	50.39K	1.82M	1.42M	580.72K	117.63K	-226.6K
Total Assets	98.13M	86.33M	102.71M	11.05M	16.06M	22.99M	27.76M	31.97M	37.97M	42.08M	44.7M	47.03M	51.31M	2.26M	2.72M	2.25M	467.34K	n/a
Account Payables	1.45M	1.03M	611.51K	2.05M	2.38M	1.83M	1.19M	1.21M	936.33K	1.49M	945.46K	454.83K	1.83M	3.08M	1.72M	1.89M	2.71M	n/a
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	7.97K	31.67K	n/a	78.2K	93.06K	91.91K	n/a	n/a	124.05K	96.4K	5.88M	n/a
Other Current Liabilities	941.7K	717.16K	552.32K	13.7K	1.16M	2.14M	2.12M	1.74M	853.51K	547.08K	355.23K	752.35K	85.53K	n/a	n/a	n/a	n/a	n/a
Total Current Liabilities	2.75M	2.33M	1.6M	2.61M	4.19M	4.6M	3.76M	3.23M	3.21M	4.01M	3.04M	1.61M	3.03M	4.41M	3.96M	3.34M	9.55M	n/a
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	27.66K	69.04K	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	21.06M	21.06M	16.36M	7.77M	n/a
Total Long-Term Liabilities	112.06K	140.2K	-345	n/a	n/a	n/a	n/a	1.24M	n/a	1.57M	7.97K	31.67K	1.83M	21.06M	21.06M	16.39M	7.84M	n/a
Total Liabilities	2.86M	2.47M	1.6M	2.61M	4.19M	4.6M	3.76M	3.23M	3.21M	4.01M	3.05M	1.64M	3.03M	25.47M	25.02M	19.73M	17.39M	n/a
Total Debt	219.38K	244.36K	n/a	n/a	n/a	n/a	7.97K	31.67K	55.08K	78.2K	101.03K	123.58K	n/a	n/a	124.05K	124.05K	5.95M	n/a
Common Stock	89.7K	75K	75K	15.97K	15.97K	15.97K	15.97K	15.97K	15.97K	15.97K	15.97K	15.97K	15.97K	348.00	342.00	33.00	332.00	n/a
Retained Earnings	-94.78M	-91.44M	-73.98M	-71.72M	-68.05M	-61.28M	-55.41M	-50.4M	-44.09M	-40.53M	-36.68M	-32.69M	-29.25M	-26.16M	-24.72M	-19.69M	-18.8M	n/a
Comprehensive Income	n/a	n/a	n/a	-0.00	n/a	n/a	-0.00	0.00	n/a	0.00	0.00	n/a	0.00	-14.64M	-21.06M	-16.36M	-7.74M	-23.96M
Shareholders Equity	95.27M	83.86M	101.1M	8.44M	11.87M	18.38M	24M	28.73M	34.76M	38.07M	41.65M	45.39M	48.27M	-23.21M	-22.3M	-17.48M	-16.92M	-23.96M
Total Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	50.39K	n/a	n/a	n/a	n/a	453.21K